Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03906708 · ClinicalTrials.gov registry record
Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature
A clinical trial of Premature Lungs, sponsored by Indiana University.
- Active
- Registry status
- 249
- Enrollment target
- 1
- Study location
NCT03906708: Active study of Premature Lungs, sponsored by Indiana University.
NCT03906708 is a study of Premature Lungs that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 249 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03906708, a study of Premature Lungs, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- 249 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine if infants are more likely to suffer from respiratory complications during their first year of life due to being born premature.
Primary Outcome
To characterize respiratory phenotypes through specific physiologic measures that quantify and identify predominant small airways, parenchymal and vascular dysfunction at 4 months CA and determine whether these phenotypes define risks for late respiratory morbidity during infancy.
Conditions Studied
Interventions
- OTHER Diffusion Capacity of the Lung for Carbon Monoxide (DLCO)
Study Locations (1)
Indiana
- Jeff Bjerregaard - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2026-12 |
What the registry record for NCT03906708 still lists
NCT03906708 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Premature Lungs appearing as the primary indexed condition, and to 1 intervention - of which Diffusion Capacity of the Lung for Carbon Monoxide (DLCO) is the first listed.
NCT03906708 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03906708 about?
NCT03906708 is a clinical study titled "Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature". The purpose of this study is to examine if infants are more likely to suffer from respiratory complications during their first year of life due to being born premature.
What is the current status of trial NCT03906708?
This trial is currently active not recruiting. The enrollment target is 249 participants. The study started on 2019-01-01. Estimated completion is 2026-12.
What conditions does trial NCT03906708 study?
This clinical trial studies the following conditions: Premature Lungs.
What interventions are being tested in trial NCT03906708?
The interventions under investigation include: Diffusion Capacity of the Lung for Carbon Monoxide (DLCO) (OTHER).
Who is sponsoring clinical trial NCT03906708?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03906708 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Lungs
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI